A calcium channel inhibitor
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Darodipine

Item No. 41667

Technical Information
Formal Name
4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid, 3,5-diethyl ester
CAS Number
72803-02-2
Synonyms
  • PY 108-068
Molecular Formula
C19H21N3O5
Formula Weight
Purity
≥95%
Formulation
A solid
Acetonitrile: Slightly soluble: 0.1-1 mg/mlDMSO: Sparingly soluble: 1-10 mg/ml
SMILES
CC1=C(C(OCC)=O)C(C(C(OCC)=O)=C(N1)C)C2=CC=CC3=NON=C32
InChi Code
InChI=1S/C19H21N3O5/c1-5-25-18(23)14-10(3)20-11(4)15(19(24)26-6-2)16(14)12-8-7-9-13-17(12)22-27-21-13/h7-9,16,20H,5-6H2,1-4H3
InChi Key
QERUYFVNIOLCHV-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    Darodipine is a calcium channel inhibitor.1 It selectively inhibits calcium-induced contractions of isolated rabbit aorta (pD2 = 8.8) over norepinephrine-, serotonin-, or angiotensin II-induced contractions at 10 µM. In vivo, continuous infusion of darodipine (2 µg/kg per minute) increases cerebral tissue oxygenation in a cat model of focal ischemia induced by cerebral artery occlusion (CAO).2 Darodipine (5 mg/kg) reduces mean arterial blood pressure and increases arterial luminal area in spontaneously hypertensive rats (SHRs).3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Hof, R.P., Vuorela, H.J., and Neumann, P. PY 108-068, a new, potent, and selective inhibitor of calcium-induced contraction of rabbit aortic rings. J. Cardiovasc. Pharmacol. 4(3), 344-351 (1982).

    2. Wiernsperger, N., Gygax, P., and Hofmann, A. Calcium antagonist PY 108-068: Demonstration of its efficacy in various types of experimental brain ischemia. Stroke 15(4), 679-685 (1984).

    3. Ferrante, F., Ricci, A., Rossodivita, I., et alInfluence of treatment with the calcium channel blocker darodipine (PY 108-068) on the morphology of pial and coronary arteries in spontaneously hypertensive rats. Clin. Exp. Hypertens. 16(3), 341-357 (1994).